Marc‐Oliver Grimm
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Pulmonary and Respiratory Medicine top 0.5%
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
Papers in
-
- Renal cell carcinoma treatment 81
- Prostate Cancer Treatment and Research 32
- Prostate Cancer Diagnosis and Treatment 22
- Urology 24
- Co-authors
- Elizabeth R. PlimackR. AckermannManfred P. WirthJens BedkeMargitta RetzAndrea NecchiJosé Ángel ArranzChikara Οhyama
- Journals
- Journal of Clinical Oncology (32 papers)Annals of Oncology (16 papers)The Journal of Urology (11 papers)European Urology (8 papers)Cancers (5 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Marc‐Oliver Grimm
218 papers receiving 5.7k citations
Hit Papers
Peers
Comparison fields: 5 of 129
- Oncology 2.5k
- Pulmonary and Respiratory Medicine 2.5k
- Urology 433
- Surgery 2.4k
- Cancer Research 759
Countries citing papers authored by Marc‐Oliver Grimm
This map shows the geographic impact of Marc‐Oliver Grimm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc‐Oliver Grimm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc‐Oliver Grimm more than expected).
Fields of papers citing papers by Marc‐Oliver Grimm
This network shows the impact of papers produced by Marc‐Oliver Grimm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc‐Oliver Grimm. The network helps show where Marc‐Oliver Grimm may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc‐Oliver Grimm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 12 | |
| 10 | 2023 | 14 | |
| 11 | 2022 | 1 | |
| 12 | 2022 | 10 | |
| 13 | 2022 | 7 | |
| 14 | 2021 | 15 | |
| 15 | 2021 | 9 | |
| 16 | 2021 | 14 | |
| 17 | 2021 | 30 | |
| 18 | 2020 | 1 | |
| 19 | 2017 | 9 | |
| 20 | 1994 | 33 |
About Marc‐Oliver Grimm
Marc‐Oliver Grimm is a scholar working on Pulmonary and Respiratory Medicine, Urology, Oncology, Surgery and Cancer Research, having authored 243 papers that have together received 5.8k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (81 papers), Bladder and Urothelial Cancer Treatments (80 papers), Cancer Immunotherapy and Biomarkers (60 papers), Urinary and Genital Oncology Studies (35 papers), Renal and related cancers (33 papers), Prostate Cancer Treatment and Research (32 papers), Cancer Genomics and Diagnostics (23 papers) and Prostate Cancer Diagnosis and Treatment (22 papers). The work is most often cited by research in Oncology (2.5k citations), Pulmonary and Respiratory Medicine (2.5k citations), Urology (433 citations), Surgery (2.4k citations) and Cancer Research (759 citations). Marc‐Oliver Grimm has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Elizabeth R. Plimack, R. Ackermann, Manfred P. Wirth, Jens Bedke, Margitta Retz, Andrea Necchi, José Ángel Arranz, Chikara Οhyama, Sergio Bracarda and Ari David Baron. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Journal of Urology, European Urology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.